Danaher earnings were $3.9B for the trailing 12 months ending Dec 31, 2024, with -17.2% growth year over year. The latest DHR earnings report on Dec 31, 2024 announced Q4 2024 earnings of $1.1B, up 32.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DHR reported annual earnings of $3.9B, with -17.8% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q4 2024 earnings per share (EPS) of $1.50, up 2.74% year over year. Total DHR earnings for the quarter were $1.09 billion. In the same quarter last year, Danaher's earnings per share (EPS) was $1.46.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $3.90 billion, a 18.16% decrease year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown -17.24% year over year. This is 16.71 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -0.53%. DHR earnings in the past year totalled $3.90 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.